MacroGenics Price to Book Ratio 2012-2025 | MGNX
Historical price to book ratio values for MacroGenics (MGNX) over the last 10 years. The current price to book ratio for MacroGenics as of June 27, 2025 is 0.95.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| MacroGenics Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-06-27 | 1.19 | 0.95 | |
| 2025-03-31 | 1.27 | $1.25 | 1.01 |
| 2024-12-31 | 3.25 | $1.85 | 1.76 |
| 2024-09-30 | 3.29 | $1.91 | 1.72 |
| 2024-06-30 | 4.25 | $0.92 | 4.61 |
| 2024-03-31 | 14.72 | $1.70 | 8.68 |
| 2023-12-31 | 9.62 | $2.46 | 3.91 |
| 2023-09-30 | 4.66 | $3.13 | 1.49 |
| 2023-06-30 | 5.35 | $2.77 | 1.93 |
| 2023-03-31 | 7.17 | $1.77 | 4.06 |
| 2022-12-31 | 6.71 | $2.30 | 2.92 |
| 2022-09-30 | 3.46 | $2.00 | 1.73 |
| 2022-06-30 | 2.95 | $2.32 | 1.27 |
| 2022-03-31 | 8.81 | $2.91 | 3.03 |
| 2021-12-31 | 16.05 | $3.91 | 4.11 |
| 2021-09-30 | 20.94 | $4.76 | 4.40 |
| 2021-06-30 | 26.86 | $5.31 | 5.06 |
| 2021-03-31 | 31.85 | $5.84 | 5.45 |
| 2020-12-31 | 22.86 | $5.26 | 4.35 |
| 2020-09-30 | 25.19 | $5.19 | 4.85 |
| 2020-06-30 | 27.92 | $4.64 | 6.01 |
| 2020-03-31 | 5.82 | $3.88 | 1.50 |
| 2019-12-31 | 10.88 | $4.71 | 2.31 |
| 2019-09-30 | 12.76 | $5.22 | 2.45 |
| 2019-06-30 | 16.97 | $6.02 | 2.82 |
| 2019-03-31 | 17.98 | $6.57 | 2.74 |
| 2018-12-31 | 12.70 | $5.73 | 2.21 |
| 2018-09-30 | 21.44 | $6.69 | 3.20 |
| 2018-06-30 | 20.65 | $7.39 | 2.79 |
| 2018-03-31 | 25.16 | $6.68 | 3.77 |
| 2017-12-31 | 19.00 | $8.12 | 2.34 |
| 2017-09-30 | 18.48 | $5.15 | 3.59 |
| 2017-06-30 | 17.51 | $6.31 | 2.78 |
| 2017-03-31 | 18.60 | $6.71 | 2.77 |
| 2016-12-31 | 20.44 | $7.71 | 2.65 |
| 2016-09-30 | 29.91 | $8.62 | 3.47 |
| 2016-06-30 | 26.99 | $9.51 | 2.84 |
| 2016-03-31 | 18.75 | $8.29 | 2.26 |
| 2015-12-31 | 30.97 | $9.12 | 3.39 |
| 2015-09-30 | 21.42 | $9.91 | 2.16 |
| 2015-06-30 | 37.97 | $7.03 | 5.40 |
| 2015-03-31 | 31.37 | $7.69 | 4.08 |
| 2014-12-31 | 35.07 | $4.33 | 8.10 |
| 2014-09-30 | 20.90 | $5.01 | 4.17 |
| 2014-06-30 | 21.73 | $5.12 | 4.24 |
| 2014-03-31 | 27.83 | $5.57 | 4.99 |
| 2013-12-31 | 27.43 | $3.13 | 8.75 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.075B | $0.150B |
| MacroGenics Inc. is a biopharmaceutical company. It is focused on discovering and developing innovative monoclonal antibody-based therapeutics. The Company has a diverse portfolio of product candidates focused in three therapeutic areas: oncology, autoimmune disorders and infectious diseases. MacroGenics Inc. is headquartered in Rockville, Maryland. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.799B | 28.11 |
| Boston Scientific (BSX) | United States | $157.605B | 39.46 |
| Stryker (SYK) | United States | $150.214B | 31.41 |
| EssilorLuxottica (ESLOY) | France | $126.765B | 0.00 |
| Medtronic (MDT) | Ireland | $110.324B | 15.64 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.804B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.676B | 26.62 |
| ResMed (RMD) | United States | $37.413B | 28.10 |
| GE HealthCare Technologies (GEHC) | United States | $34.057B | 16.17 |
| Agilent Technologies (A) | United States | $33.852B | 22.07 |
| Terumo (TRUMY) | Japan | $27.835B | 36.15 |
| Koninklijke Philips (PHG) | Netherlands | $23.245B | 16.31 |
| Insulet (PODD) | United States | $22.033B | 86.49 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.095B | 11.62 |
| Baxter (BAX) | United States | $15.595B | 11.64 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.236B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.639B | 23.10 |
| Lantheus Holdings (LNTH) | United States | $5.638B | 14.22 |
| Prestige Consumer Healthcare (PBH) | United States | $3.998B | 17.86 |
| Perrigo (PRGO) | Ireland | $3.649B | 9.25 |
| Haemonetics (HAE) | United States | $3.545B | 16.15 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.334B | 27.70 |
| ICU Medical (ICUI) | United States | $3.244B | 23.92 |
| QuidelOrtho (QDEL) | United States | $1.952B | 13.43 |
| LeMaitre Vascular (LMAT) | United States | $1.866B | 41.70 |
| AtriCure (ATRC) | United States | $1.598B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.289B | 13.08 |
| Acuren (TIC) | United States | $1.271B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.111B | 25.00 |
| Phibro Animal Health (PAHC) | United States | $1.040B | 13.30 |
| Neogen (NEOG) | United States | $1.027B | 13.14 |
| BioLife Solutions (BLFS) | United States | $1.021B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $0.907B | 0.00 |
| InMode (INMD) | Israel | $0.897B | 9.04 |
| Owens & Minor (OMI) | United States | $0.685B | 5.69 |
| CeriBell (CBLL) | United States | $0.683B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.629B | 0.00 |
| Evolus (EOLS) | United States | $0.589B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.531B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.509B | 0.00 |
| Valneva SE (VALN) | France | $0.494B | 0.00 |
| Surmodics (SRDX) | United States | $0.412B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.403B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.354B | 13.00 |
| Quanterix (QTRX) | United States | $0.332B | 0.00 |
| SNDL (SNDL) | Canada | $0.323B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.301B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.274B | 23.07 |
| Cerus (CERS) | United States | $0.271B | 0.00 |
| ZimVie (ZIMV) | United States | $0.258B | 11.72 |
| Sanuwave Health (SNWV) | United States | $0.256B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.253B | 0.00 |
| Brainsway (BWAY) | Israel | $0.250B | 66.10 |
| Cresco Labs (CRLBF) | United States | $0.246B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.233B | 69.17 |
| Biote (BTMD) | United States | $0.230B | 6.46 |
| OraSure Technologies (OSUR) | United States | $0.225B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.224B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.201B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.188B | 15.29 |
| Omeros (OMER) | United States | $0.188B | 0.00 |
| High Tide (HITI) | Canada | $0.184B | 0.00 |
| Organigram Global (OGI) | Canada | $0.181B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.177B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.144B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.120B | 14.81 |
| Jin Medical (ZJYL) | China | $0.102B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 11.90 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.082B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| Zynex (ZYXI) | United States | $0.077B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.077B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.077B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.061B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 55.14 |
| United-Guardian (UG) | United States | $0.037B | 12.94 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.027B | 0.00 |
| Safety Shot (SHOT) | United States | $0.023B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |